Related Experiment Video
Updated: Nov 1, 2025

Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
Delivering tertiary tuberculosis care virtually
Louise Turnbull1, Christine Bell2, Stefanie Davies3
1Paediatric Respiratory Department, Royal Manchester Children's Hospital, Manchester, UK louise.turnbull@mft.nhs.uk.
Insights
Virtual multidisciplinary team (MDT) reviews improved care for children with rare diseases like tuberculosis (TB). This approach reduced travel, sped up treatment, and enhanced diagnostic accuracy, keeping care closer to home.
Area of Science:
- Pediatric infectious diseases
- Rare disease management
- Telemedicine in healthcare
Background:
- Children with rare diseases, such as tuberculosis (TB), often require specialized care that may involve significant travel.
- Access to multidisciplinary expertise is crucial for accurate diagnosis and effective management of rare pediatric conditions.
Purpose of the Study:
- To evaluate the effectiveness of a virtual multidisciplinary team (MDT) review panel in improving care for children with rare diseases.
- To assess if virtual MDT reviews can reduce patient travel without negatively impacting clinical outcomes.
Main Methods:
- A retrospective review of pediatric patients discussed in a virtual MDT panel was conducted.
- Data from Public Health England was analyzed for pre-intervention and post-intervention comparisons.
- The study included children under 16 years with suspected TB infection or disease across Paediatric departments in North West England.
Main Results:
- 45% of children received care closer to home, reducing the need for travel.
- The median time from presentation to treatment decreased by 28% (from 18 to 13 days).
- There was a 21% increase in children diagnosed before symptom onset, and 5 cases of misdiagnosed latent TB infection were corrected.
Conclusions:
- Virtual MDT reviews, as part of a clinical network, can enhance treatment for children with rare diseases.
- This model of care facilitates improved outcomes and supports 'care closer to home' initiatives.
- Telemedicine-based specialist consultations are effective in managing complex pediatric cases remotely.
Objective:
To assess the impact of a virtual multidisciplinary team (MDT) review panel in reducing travel for children with a rare disease (tuberculosis (TB)) without compromising clinical outcomes.
Design:
Retrospective review of patients discussed in a virtual MDT panel. Independent pre-intervention and post-intervention data from Public Health England.
Setting:
Paediatric departments across North West England.
Patients:
Children aged <16 years with suspected TB infection/disease.
Intervention:
Weekly, virtual MDT discussion between district paediatricians and a tertiary TB team.
Main Outcome Measure:
Care closer to home, time from presentation to treatment.
Results:
45% (37 of 82) children received care closer to home. Median time from presentation to treatment reduced by 28% (from 18 to 13 days). 21% more children were diagnosed before developing symptoms (76% of children presented with symptoms pre-intervention, 55% post-intervention). 5 children incorrectly labelled with latent TB infection were treated for TB disease.
Conclusions:
A clinical network supported by virtual MDT reviews can improve treatment for children with rare diseases while providing care close to home.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tertiary Healthcare System

